ClinicalTrials.gg
RecruitingNCT06766448Updated Feb 3, 2025

Effectiveness of Instrumental Rehabilitation in Patients With Adhesive Capsulitis

An interventional study of robotic training and conventionnal rehabilitation in Adhesive Capsulitis of the Shoulder, sponsored by Mohammed V Souissi University. Recruiting at 1 site in Morocco. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-03.

Sponsored by Mohammed V Souissi University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 9 months after the study started (first participant enrolled Mar 2021, registered Jan 2025).
  • Started Mar 2021; still recruiting 5 years 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to evaluate the effectiveness of robotic training compared to conventional rehabilitation in patients with AC.

Read the detailed description

Nowadays, rehabilitation focuses on functional work during physiotherapy sessions to improve the patient's autonomy.

In the era of new technologies, robotics and virtual reality have shown great interest in functional rehabilitation and cortical reorganization.

02

Conditions studied

  • Adhesive Capsulitis of the Shoulder

Browse trials for

Keywords

  • adhesive capsulitis
  • rehabilitation
  • robotic training
03

In context

Bursitis

383 studies on the registry are indexed under Bursitis; 111 are open to participants now.

This study's planned enrollment of 70 is above the median of 44 across 346 interventional studies indexed under Bursitis.

Browse Bursitis studies →

Lead sponsor

Mohammed V Souissi University is the lead sponsor of 5 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients >18 years of age
  • Shoulder pain and/or movement limitation
  • Idiopathic AC or associated with confirmed systemic disease (e.g., diabetes or dyslipidemia)

Exclusion criteria

Exclusion Criteria:

  • Cognitive impairment
  • History of surgery
  • Fracture or dislocation of the shoulder
  • History of shoulder tendinopathy
  • History of inflammatory or degenerative disease
  • Infection
  • Neurological disease (Parkinson's disease, stroke, multiple sclerosis, neurological
  • Manipulation under anesthesia, hydro dilation, rich plasma or hyaluronic acid infiltration within the last 6 months
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Platelets

Blood cells that help blood clot. Too few raises the risk of bleeding and bruising. A usual adult range is about 150–400 × 10⁹/L (150,000–400,000 per µL); each lab has its own reference range.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    intervention group

    the intervention group will receive robotic training

    Other: robotic training

  • Active comparator
    control group

    control group will receive conventionnal rehabilitation

    Other: conventionnal rehabilitation

Interventions

  • Otherrobotic training

    continuous passive mobilization and robotic therapy on armeo sping

  • Otherconventionnal rehabilitation

    rehabilitation sessions with a physiotherapist

06

What researchers measure

Primary outcomes

  1. shoulder fonction using Shoulder Pain and Disability Index (SPADI)

    It is a self-written questionnaire. It consists of twosubscales. The first assesses the importance of pain felt on five items. Pain scores range from 0 to 50. The second evaluates the difficulty of activities of daily living based on eight. Scores range from 0 to 80.questions

    Time frame: at 3 weeks, 6 weeks, 3 months, 6 months, 9 months and 12 months

Secondary outcomes

  1. pain using a visual analogue scale

    It is a 100mm ruler that allows patients to rank their pain on a continuum from no pain to extreme pain. The patient places the indicator on a level that represents their current pain.

    Time frame: at 3 weeks, 6 weeks, 3 months, 6 months, 9 months and 12 months

  2. Active and passive range of motion

    Active and passive range of motion is clinically assessed using a goniometer while standing. We measured abduction, extension and external rotation.

    Time frame: at 3 weeks, 6 weeks, 3 months, 6 months, 9 months and 12 months

07

Study locations

1 of 1 sites recruiting
  • Faculty of medecine and pharmacy of rabat
    Rabat, 10000, Morocco
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — excell table of data

Supporting information: Study protocol, Statistical analysis plan

Time frame: start january 2025 end may 2025

Access criteria: doctors in the rehabilitation field can ask access by sending an email to the principal investigator

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06766448
Lead sponsor
Mohammed V Souissi University
Responsible party
SARA SKALLI (assistant professor, Mohammed V Souissi University) — Principal investigator
First posted
Jan 9, 2025
Start date
Mar 23, 2021
Primary completion
Jan 2, 2025
Completion
Apr 2025 (estimated)
Last update
Feb 3, 2025

Study contacts

sara skalli, doctor
Contact
dr.skalli.sara@gmail.com
+212661504251
samia karkouri, professor
study chair · Mohammed V Souissi University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion